Goldman Sachs’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
47,428
+6,671
+16% +$263K ﹤0.01% 4661
2026
Q1
$1.36M Buy
+40,757
New +$1.51M ﹤0.01% 4866
2025
Q4
Sell
-45,785
Closed -$1.71M 6555
2025
Q3
$1.71M Buy
+45,785
New +$1.58M ﹤0.01% 4607
2025
Q2
Sell
-14,249
Closed -$384K 6181
2025
Q1
$384K Sell
14,249
-32,254
-69% -$946K ﹤0.01% 5345
2024
Q4
$1.33M Buy
46,503
+25,995
+127% +$756K ﹤0.01% 4615
2024
Q3
$552K Sell
20,508
-3,159
-13% -$83.2K ﹤0.01% 4999
2024
Q2
$657K Sell
23,667
-13,377
-36% -$365K ﹤0.01% 4678
2024
Q1
$1.02M Buy
+37,044
New +$968K ﹤0.01% 4335
2022
Q4
Sell
-25,490
Closed -$623K 6071
2022
Q3
$623K Buy
+25,490
New +$706K ﹤0.01% 4827
2022
Q2
Sell
-14,876
Closed -$582K 6535
2022
Q1
$582K Buy
14,876
+5,100
+52% +$198K ﹤0.01% 5214
2021
Q4
$448K Buy
+9,776
New +$467K ﹤0.01% 5451

Other funds holding FFTY

Goldman Sachs's FFTY Position: Q2 2026 in Review

Goldman Sachs increased its CapForce IBD 50 ETF (FFTY) stake by 16% in Q2 2026, buying an estimated $263K and bringing the position to 47,428 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4661.

Goldman Sachs first reported a position in FFTY in Q4 2021 and has held it in 11 quarters since. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

  • Goldman Sachs held 47,428 shares of CapForce IBD 50 ETF worth $2.07M as of Q2 2026.
  • Goldman Sachs bought 6,671 CapForce IBD 50 ETF shares in Q2 2026, an estimated $263K.
  • CapForce IBD 50 ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4661 holding.
  • Goldman Sachs first reported a position in CapForce IBD 50 ETF in Q4 2021 and has held it in 11 quarters since.
  • 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.